China Shineway Pharmaceutical Group Limited (HKG: 2877)

China Shineway Pharmaceutical Group Revenue

China Shineway Pharmaceutical Group had revenue of 2.09B CNY in the half year ending June 30, 2024, with 14.96% growth. This brings the company's revenue in the last twelve months to 4.20B, down -7.27% year-over-year. In the year 2023, China Shineway Pharmaceutical Group had annual revenue of 4.52B with 14.32% growth.

• Revenue (ttm): 4.20B CNY
• Revenue Growth: -7.27%
• P/S Ratio: 1.41
• Revenue / Employee: 1.22M CNY
• Employees: 3,436
• Market Cap: 6.35B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	4.52B	565.90M	14.32%
Dec 31, 2022	3.95B	727.09M	22.56%
Dec 31, 2021	3.22B	567.85M	21.38%
Dec 31, 2020	2.66B	-50.30M	-1.86%
Dec 31, 2019	2.71B	135.80M	5.28%